Search Results
Facet (Page)
Refine Your Search
Audiences
Content Formats
Events
Sections
Divisions
Profile
After major advances in hematology, David Bodine retires with an eye towards mentorship and a garden
David Bodine, founder of the Hematopoiesis Section and chief of the Genetics and Molecular Biology Branch, advanced the fields of gene therapy and hematology in his 38 years at the NIH. Now, he plans to continue his contributions to science as an emeritus and through training the next generation of scientists.
… Bodine, leader of the NHGRI Hematopoiesis Section and chief … Rogers: How did you first get interested in science? David Bodine: I would never have gotten into science if it … That's probably going to keep me pretty busy. … When David M. Bodine, Ph.D. , arrived at the National Institutes …
News Release
NHGRI researchers have discovered a new inflammatory disorder called vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic syndrome (VEXAS), which is caused by mutations in the UBA1 gene.
… Center, and we were just unable to diagnose them,” said David B. Beck, M.D., Ph.D., clinical fellow at NHGRI and lead … disorders, ubiquitylation, Undiagnosed Disease Program, David Beck, Dan Kastner … NHGRI researchers have discovered a …
Event
On June 17-18, 2021, NHGRI hosts a workshop, Multi-Omics in Health and Disease: Current Applications, Challenges and Future Directions.
… Data Integration and Study Design Moderator: Dave Bodine, NHGRI 2:45 - 3:05 p.m. Presentation 1 - Experimental … Lessons Learned From Moving Genomics Into the Clinic David Craig, University of Southern California 3:25 - 4:00 …
News Release
Using a recently developed DNA base-editing technique, researchers correct accelerating aging disorder.
… and even more dramatic treatment option in the future. David Liu, Ph.D., and his lab at the Broad Institute …
News Release
Research points to the effects of nutrients in how DNA mutates in the mitochondria.
… exists in the mitochondria. This work was led by NHGRI’s David Bernard and Darren Walsh, a graduate student at Dublin …
News Release
Doctors and researchers reunite with patient who received gene therapy for GM1 gangliosidosis.
… “The difference is night and day,” said Jojo’s father, David. “Looking at the girl she was before and how she is …
Event
NHGRI workshop seeking scientific perspectives for relating genomic variation to human phenotype.
… Health and Disease Panel: Barbara Stranger Anshul Kundaje David Valle Moderator: Michael Boehnke 4:45 - 5:30 p.m. Topic …
Event
On November 1-5, 2023, the National Human Genome Research Institute (NHGRI) will participate in the ASHG Annual Meeting - the world's largest human genetics and genomics meeting and exposition. The annual meeting provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics.
… expands the phenotypic spectrum of disease. PB3464 David Bernard Vitamin B12-deficient mice lacking the … Gene Therapy Education for Patient Communities. PB2369 David Adams Development of a comprehensive framework for …
Event
A joint NHGRI-NCATS hosted meeting bringing together researchers, clinicians, families and patient advocates from around the world to discuss the natural history, disease pathophysiology, genetics and treatments for rare inborn metabolic errors.
… in the Inborn Errors of Vitamin B12 (cobalamin) Metabolism David S. Rosenblatt, M.D. 10:30 - 10:45 a.m. High-Dose B12 … M.D., Ph.D., Senior Investigator, NHGRI Panelists: David S. Rosenblatt, Harvey Levy, Marzia Pasquali, Martina …
Event
On October 25-29, 2022, the National Human Genome Research Institute (NHGRI) will participate in the ASHG Annual Meeting - the world's largest human genetics and genomics meeting and exposition.
… Rare Disease Phenotyping: What is Next? Board No. PB3237 David Adams Convention Center, South Exhibit Hall 3:00 p.m. — … in the All of Us Research Program Board No. PB2109 David Schlueter Convention Center, South Exhibit Hall 3:00 … of coding variants, from benchtop to desktop David Adams Convention Center, Petree C/West Building 5:15 …